Project Number 5R21AG046526-02 Agency/Funding Organization NIA Funding Year 2015 View Full Project Details for SCREENING FOR INHIBITORS OF P300-MEDIATED TAU ACETYLATION FOR ALZHEIMER'S DISEASE Research Categorization Primary Disease / Condition Alzheimer's Disease Frontotemporal Dementia CADRO Category C. Translational Research and Clinical Interventions 3. Drug Discovery (small molecules and biologics) b. Tau Researcher and Organization Principal Investigator Arkin, Michelle Principal Investigator First Name Michelle Principal Investigator Last Name Arkin Awardee Organization University of California San Francisco Awardee State California Contact PI Country United States Project Detail Funding Opportunity Announcement PAR-13-049: Drug Discovery for Nervous System Disorders (R21) FY Overall Cost $245,895 Funding Organization Agency/Funding Organization NIA Funding Organization Country United States Program Official REFOLO, LORENZO
